Mode
Text Size
Log in / Sign up

Gastrointestinal

7 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for gastrointestinal

24 trials tracked for gastrointestinal: 7 in phase 3 or 4 and 2 with published results. The most-cited published study has 382 citations.

24Trials tracked
7Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 5 Phase 3 2 Phase 2 5 Phase 1 1 Other / NA 11
  1. Phase 3 Cholestasis Reversal: Efficacy of IV Fish Oil Completed · 382 cited
  2. Phase 4 Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Completed · 25 cited
  3. Phase 4 A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults Completed
  4. Phase 4 Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions Completed
  5. Phase 4 Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant Recipients Completed
  6. Phase 4 Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy Completed
Show 18 more trials
  1. Phase 3 Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal Endoscopy Completed
  2. Phase 2 Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients Completed
  3. Phase 2 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Completed
  4. Phase 2 Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis Completed
  5. Phase 2 The EVICEL® Gastrointestinal Study Completed
  6. Phase 2 A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System Completed
  7. Phase 1 Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants Completed
  8. N/A Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique Completed
  9. N/A Myoelectric Activity Following Colorectal Surgery and Return of Bowel Function Completed
  10. N/A Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic Completed
  11. N/A Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia Completed
  12. N/A Ultraviolet Light And Vitamin D In Subjects With Fat Malabsorption Or After Gastric Bypass Surgery Completed
  13. N/A Virtual Path Planning for Image-guided Needle Interventions Completed
  14. N/A Gastrointestinal Myoelectric Activity Protocol, the G-Tech EEnG Protocol Completed
  15. N/A Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System Completed
  16. N/A Probability Ramp Control of Propofol for EGD Completed
  17. N/A Probiotics and Infections in Conscripts in Military Service Completed
  18. N/A An Open-label, Randomized, Prospective Study of the Effectiveness, Safety, and Clinical Outcomes of Stapled Anastomoses Versus Hand-Sutured Anastomoses in Patients Undergoing Gastrointestinal End to End or Side to Side Anastomoses Completed

Showing the 24 most-cited and recently-updated of 24 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Gastrointestinal: what the trials found

Clinical trials for gastrointestinal conditions have evaluated various pharmacological and monitoring interventions. Liposomal bupivacaine was assessed for post-operative pain management, resulting in a score of 4 on the Visual Analog Scale 1. Mycophenolate Sodium 2, IDIAZOLE 20mg DR tabs [3, 4], and Vigileo Monitor 5 were also evaluated in established trials.

In studies regarding cholestasis, Omegaven® demonstrated a significant reversal of cholestasis (defined as Direct Bilirubin to > 2.0 mg/dL) with results of 11.7 and 6.4 (p=0.001) 6. Additionally, Dexmedetomidine was evaluated in a Phase 3 trial for gastrointestinal-related outcomes 7.

Recent results — preliminary, needs further review

  • G-tech WPS was evaluated in a recent study 14.

For the clinician treating this condition

  • Omegaven® showed statistically significant results in reversing cholestasis (p=0.001) 6.
  • Liposomal bupivacaine was utilized to manage post-operative pain scores 1.

AI synthesis of 6 cited trials, updated Jun 23, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about gastrointestinal

Does Bifidobacterium longum BB536 improve gastrointestinal symptoms in athletes?

In athletes, Bifidobacterium longum BB536 did not significantly improve gastrointestinal symptoms overall, though some benefits were seen in specific subgroups.

Full answer →
Can auricular vagus nerve stimulation help with gastrointestinal disorders?

Yes, early evidence suggests transcutaneous auricular vagus nerve stimulation may improve symptoms in some gastrointestinal disorders, especially constipation-predominant IBS, but more research is needed.

Full answer →